FUMAGALLI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 81
EU - Europa 79
AS - Asia 17
Totale 177
Nazione #
US - Stati Uniti d'America 81
SE - Svezia 43
IT - Italia 23
CN - Cina 12
FI - Finlandia 4
DE - Germania 3
IE - Irlanda 3
GB - Regno Unito 2
IN - India 2
SG - Singapore 2
MK - Macedonia 1
TW - Taiwan 1
Totale 177
Città #
Ashburn 19
Shanghai 12
Lawrence 9
Princeton 9
Helsinki 4
New York 4
Ancona 3
Dublin 3
Arezzo 2
Clusone 2
Genoa 2
Guildford 2
Hanover 2
Los Angeles 2
Milan 2
Pune 2
Seattle 2
Vimodrone 2
Washington 2
Bacoli 1
Baltimore 1
Benevento 1
Chiaravalle 1
Mountain View 1
Rome 1
Segrate 1
Skopje 1
Totale 93
Nome #
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming 28
Isolation of mouse Kupffer cells for phenotypic and functional studies 20
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 17
Extracellular HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV pathogenesis 17
A subset of Kupffer cells regulates metabolism through the expression of CD36 17
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion 16
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming 15
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability 15
Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection 13
Effector CD8+T cell-derived interleukin-10 enhances acute liver immunopathology 10
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection 9
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence 9
Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development 8
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus 5
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 5
A fluorescent reporter model for the visualization and characterization of TDC 5
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination 4
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses 3
The interplay of drug therapeutics and immune responses to SARS-CoV-2 2
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses 1
Totale 219
Categoria #
all - tutte 2.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 1 1 0 0 0 0 0 0 0
2020/20212 0 0 0 1 0 1 0 0 0 0 0 0
2021/202220 0 0 0 3 1 0 7 2 1 0 2 4
2022/202384 22 19 10 2 2 11 9 7 0 1 0 1
2023/2024109 12 6 10 18 9 17 1 10 11 9 6 0
Totale 219